Biometric monitoring devices for assessing end points in clinical trials: Developing an ecosystem

Stephen P. Arneric; Jesse M. Cedarbaum; Sean Khozin; Spyros Papapetropoulos; Derek L. Hill; Michael Ropacki; Jane Rhodes; Penny A. Dacks; Lynn D. Hudson; Mark Forrest Gordon; Volker D. Kern; Klaus Romero; George Vradenburg; Rhoda Au; Daniel R. Karlin; Maurizio F. Facheris; Cheryl J. Fitzer-Attas; Ottavio V. Vitolo; Jian Wang; Bradley M. Miller; Jeffrey A. Kaye

doi:10.1038/nrd.2017.153

Biometric monitoring devices for assessing end points in clinical trials: Developing an ecosystem

Stephen P. Arneric, Jesse M. Cedarbaum, Sean Khozin, Spyros Papapetropoulos, Derek L. Hill, Michael Ropacki, Jane Rhodes, Penny A. Dacks, Lynn D. Hudson, Mark Forrest Gordon, Volker D. Kern, Klaus Romero, George Vradenburg, Rhoda Au, Daniel R. Karlin, Maurizio F. Facheris, Cheryl J. Fitzer-Attas, Ottavio V. Vitolo, Jian Wang, Bradley M. MillerJeffrey A. Kaye

Neurology

Research output: Contribution to journal › Letter › peer-review

21 Scopus citations

Original language	English (US)
Pages (from-to)	736
Number of pages	1
Journal	Nature Reviews Drug Discovery
Volume	16
Issue number	10
DOIs	https://doi.org/10.1038/nrd.2017.153
State	Published - Oct 1 2017

ASJC Scopus subject areas

Pharmacology
Drug Discovery

Access to Document

10.1038/nrd.2017.153

Cite this

Arneric, S. P., Cedarbaum, J. M., Khozin, S., Papapetropoulos, S., Hill, D. L., Ropacki, M., Rhodes, J., Dacks, P. A., Hudson, L. D., Gordon, M. F., Kern, V. D., Romero, K., Vradenburg, G., Au, R., Karlin, D. R., Facheris, M. F., Fitzer-Attas, C. J., Vitolo, O. V., Wang, J., ... Kaye, J. A. (2017). Biometric monitoring devices for assessing end points in clinical trials: Developing an ecosystem. Nature Reviews Drug Discovery, 16(10), 736. https://doi.org/10.1038/nrd.2017.153

Biometric monitoring devices for assessing end points in clinical trials : Developing an ecosystem. / Arneric, Stephen P.; Cedarbaum, Jesse M.; Khozin, Sean; Papapetropoulos, Spyros; Hill, Derek L.; Ropacki, Michael; Rhodes, Jane; Dacks, Penny A.; Hudson, Lynn D.; Gordon, Mark Forrest; Kern, Volker D.; Romero, Klaus; Vradenburg, George; Au, Rhoda; Karlin, Daniel R.; Facheris, Maurizio F.; Fitzer-Attas, Cheryl J.; Vitolo, Ottavio V.; Wang, Jian; Miller, Bradley M.; Kaye, Jeffrey A.

In: Nature Reviews Drug Discovery, Vol. 16, No. 10, 01.10.2017, p. 736.

Research output: Contribution to journal › Letter › peer-review

Arneric, SP, Cedarbaum, JM, Khozin, S, Papapetropoulos, S, Hill, DL, Ropacki, M, Rhodes, J, Dacks, PA, Hudson, LD, Gordon, MF, Kern, VD, Romero, K, Vradenburg, G, Au, R, Karlin, DR, Facheris, MF, Fitzer-Attas, CJ, Vitolo, OV, Wang, J, Miller, BM & Kaye, JA 2017, 'Biometric monitoring devices for assessing end points in clinical trials: Developing an ecosystem', Nature Reviews Drug Discovery, vol. 16, no. 10, pp. 736. https://doi.org/10.1038/nrd.2017.153

Arneric, Stephen P. ; Cedarbaum, Jesse M. ; Khozin, Sean ; Papapetropoulos, Spyros ; Hill, Derek L. ; Ropacki, Michael ; Rhodes, Jane ; Dacks, Penny A. ; Hudson, Lynn D. ; Gordon, Mark Forrest ; Kern, Volker D. ; Romero, Klaus ; Vradenburg, George ; Au, Rhoda ; Karlin, Daniel R. ; Facheris, Maurizio F. ; Fitzer-Attas, Cheryl J. ; Vitolo, Ottavio V. ; Wang, Jian ; Miller, Bradley M. ; Kaye, Jeffrey A. / Biometric monitoring devices for assessing end points in clinical trials : Developing an ecosystem. In: Nature Reviews Drug Discovery. 2017 ; Vol. 16, No. 10. pp. 736.

@article{55f432856b074ddb91d489ce5651f67f,

title = "Biometric monitoring devices for assessing end points in clinical trials: Developing an ecosystem",

author = "Arneric, {Stephen P.} and Cedarbaum, {Jesse M.} and Sean Khozin and Spyros Papapetropoulos and Hill, {Derek L.} and Michael Ropacki and Jane Rhodes and Dacks, {Penny A.} and Hudson, {Lynn D.} and Gordon, {Mark Forrest} and Kern, {Volker D.} and Klaus Romero and George Vradenburg and Rhoda Au and Karlin, {Daniel R.} and Facheris, {Maurizio F.} and Fitzer-Attas, {Cheryl J.} and Vitolo, {Ottavio V.} and Jian Wang and Miller, {Bradley M.} and Kaye, {Jeffrey A.}",

note = "Funding Information: This work was supported, in part, by grant number 1U18FD005320 from the U.S. Food and Drug Administration{\textquoteright}s Critical Path Public Private Partnerships Grant, and members including: AbbVie, Alzheimer{\textquoteright}s Association, Alzheimer{\textquoteright}s Disease Discovery Foundation (ADDF), Alzheimer{\textquoteright}s Research UK, AstraZeneca, Biogen, Boehringer Ingelheim, CHDI Foundation, Lilly, Merck, Novartis, Pfizer, and UsAgainstAlzheimer{\textquoteright}s.",

year = "2017",

month = oct,

day = "1",

doi = "10.1038/nrd.2017.153",

language = "English (US)",

volume = "16",

pages = "736",

journal = "Nature Reviews Drug Discovery",

issn = "1474-1776",

publisher = "Nature Publishing Group",

number = "10",

}

TY - JOUR

T1 - Biometric monitoring devices for assessing end points in clinical trials

T2 - Developing an ecosystem

AU - Arneric, Stephen P.

AU - Cedarbaum, Jesse M.

AU - Khozin, Sean

AU - Papapetropoulos, Spyros

AU - Hill, Derek L.

AU - Ropacki, Michael

AU - Rhodes, Jane

AU - Dacks, Penny A.

AU - Hudson, Lynn D.

AU - Gordon, Mark Forrest

AU - Kern, Volker D.

AU - Romero, Klaus

AU - Vradenburg, George

AU - Au, Rhoda

AU - Karlin, Daniel R.

AU - Facheris, Maurizio F.

AU - Fitzer-Attas, Cheryl J.

AU - Vitolo, Ottavio V.

AU - Wang, Jian

AU - Miller, Bradley M.

AU - Kaye, Jeffrey A.

N1 - Funding Information: This work was supported, in part, by grant number 1U18FD005320 from the U.S. Food and Drug Administration’s Critical Path Public Private Partnerships Grant, and members including: AbbVie, Alzheimer’s Association, Alzheimer’s Disease Discovery Foundation (ADDF), Alzheimer’s Research UK, AstraZeneca, Biogen, Boehringer Ingelheim, CHDI Foundation, Lilly, Merck, Novartis, Pfizer, and UsAgainstAlzheimer’s.

PY - 2017/10/1

Y1 - 2017/10/1

UR - http://www.scopus.com/inward/record.url?scp=85032508559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032508559&partnerID=8YFLogxK

U2 - 10.1038/nrd.2017.153

DO - 10.1038/nrd.2017.153

M3 - Letter

C2 - 28935908

AN - SCOPUS:85032508559

VL - 16

SP - 736

JO - Nature Reviews Drug Discovery

JF - Nature Reviews Drug Discovery

SN - 1474-1776

IS - 10

ER -